‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access

As GLP-1 weight-loss medications gain traction, the peptide market is experiencing a surge in interest.

A variety of peptides — commonly marketed for weight loss, muscle building, injury recovery and other uses — have emerged as largely unregulated drugs sold through both licensed compounding pharmacies and unverified vendors.

The U.S. Food and Drug Administration is set to evaluate whether to loosen regulations on several peptides during a meeting this summer.

THINKING ABOUT PEPTIDES?